Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the Chairman of its Scientific Advisory Board, Howard Weiner, is to receive the Giants of MS award.
The award ceremony will be held on Thursday (May 30), during the Consortium of Multiple Sclerosis Centers annual meeting in Nashville, Tennessee.
Arrow Exploration Corp's (TSX-V:AXL, AIM:AXL, OTC:CSTPF) first quarter results show revenue more than doubled year-on-year to $14.4 million from $6.9 million.
It follows a campaign of successful well drilling in Colombia, and the profile promises to step up again in the coming months as Arrow moves to horizontal well drilling – which will yield greater volumes.
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) has started the wet commissioning of its new Lafigué project in the Ivory Coast.
Construction is now 94% complete, it said, with the project on budget and the first gold pour expected to take place in late June, a quarter ahead of schedule.
Atlantic Lithium Ltd (AIM:ALL, OTCQX:ALLIF, ASX:A11) has started groundwork at Senya Beraku, a new licence in Ghana within its East African Cape Coast portfolio.
Lying 70km from Atlantic’s flagship Ewoyaa project, initial exploration will comprise geochemical soil sampling, geological mapping and rock chip gathering over the tenement’s 82.11sq km.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has received €381,434 from a research grant provided by the Government of Wallonia in Belgium.
This grant is non-diluting and non-reimbursable, meaning Genflow does not have to pay it back or give up any company ownership.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to expand its ModiFY trial to include 44 new patients with untreated renal cell carcinoma, a form of kidney cancer.
They will receive Scancell's Modi-1 cancer vaccine combined with two checkpoint inhibitors ipilimumab (Yervoy) and nivolumab (Opdivo).